Seung Up Kim - Search Results

Year	Number of Results
2002	4
2003	1
2004	4
2005	3
2006	2
2007	6
2008	10
2009	8
2010	14
2011	14
2012	33
2013	32
2014	31
2015	39
2016	33
2017	29
2018	14
2019	38
2020	50
2021	57
2022	49
2023	38
2024	17

1

Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver Disease.

Lin H, Lee HW, Yip TC, Tsochatzis E, Petta S, Bugianesi E, Yoneda M, Zheng MH, Hagström H, Boursier J, Calleja JL, Goh GB, Chan WK, Gallego-Durán R, Sanyal AJ, de Lédinghen V, Newsome PN, Fan JG, Castéra L, Lai M, Harrison SA, Fournier-Poizat C, Wong GL, Pennisi G, Armandi A, Nakajima A, Liu WY, Shang Y, de Saint-Loup M, Llop E, Teh KK, Lara-Romero C, Asgharpour A, Mahgoub S, Chan MS, Canivet CM, Romero-Gomez M, Kim SU, Wong VW; VCTE-Prognosis Study Group. Lin H, et al. Among authors: kim su. JAMA. 2024 Apr 16;331(15):1287-1297. doi: 10.1001/jama.2024.1447. JAMA. 2024. PMID: 38512249

2

Sorafenib vs. Lenvatinib in advanced hepatocellular carcinoma after Atezolizumab/Bevacizumab Failure: A real-world study.

Chon YE, Kim DY, Kim M, Kim BK, Kim SU, Park JY, Ahn SH, Ha Y, Lee JH, Lee KS, Kang B, Kim JS, Chon HJ, Kim DY. Chon YE, et al. Among authors: kim su. Clin Mol Hepatol. 2024 Mar 12. doi: 10.3350/cmh.2023.0553. Online ahead of print. Clin Mol Hepatol. 2024. PMID: 38468561 Free article.

3

Neither hepatic steatosis nor fibrosis is associated with clinical outcomes in patients with intestinal Behçet's disease.

Hyun HK, Park J, Park SJ, Park JJ, Kim TI, Lee JS, Lee HW, Kim BK, Park JY, Kim DY, Ahn SH, Kim SU, Cheon JH. Hyun HK, et al. Among authors: kim su. Eur J Gastroenterol Hepatol. 2024 Apr 1;36(4):445-451. doi: 10.1097/MEG.0000000000002711. Epub 2024 Feb 23. Eur J Gastroenterol Hepatol. 2024. PMID: 38417062

4

Corrigendum to "Mortality in metabolic dysfunction-associated steatotic liver disease: A nationwide population-based cohort study" [Metabolism, Volume 152, March 2024, 155789].

Han E, Lee BW, Kang ES, Cha BS, Ahn SH, Lee YH, Kim SU. Han E, et al. Among authors: kim su. Metabolism. 2024 May;154:155819. doi: 10.1016/j.metabol.2024.155819. Epub 2024 Feb 26. Metabolism. 2024. PMID: 38412589 No abstract available.

5

Editorial: Updated epidemiology of steatotic liver disease in people with HIV in the United States.

Manikat R, Kim SU, Ahmed A, Kim D. Manikat R, et al. Among authors: kim su. Aliment Pharmacol Ther. 2024 Mar;59(6):789-790. doi: 10.1111/apt.17871. Aliment Pharmacol Ther. 2024. PMID: 38401138 No abstract available.

6

High-dose proton pump inhibitor treatment is associated with a higher mortality in cirrhotic patients: A multicentre study.

Yoon JS, Hong JH, Park SY, Kim SU, Kim HY, Kim JY, Hur MH, Park MK, Lee YB, Lee HA, Kim GA, Sinn DH, Park SJ, Lee YJ, Kim YJ, Yoon JH, Lee JH. Yoon JS, et al. Among authors: kim su. Aliment Pharmacol Ther. 2024 Apr;59(8):973-983. doi: 10.1111/apt.17909. Epub 2024 Feb 22. Aliment Pharmacol Ther. 2024. PMID: 38389319

7

Hepatitis C virus infection in patients undergoing surgery in a single tertiary academic center.

Lee JS, Lee HW, Kim MN, Kim BK, Park JY, Kim DY, Ahn SH, Kim SU. Lee JS, et al. Among authors: kim su. J Gastroenterol Hepatol. 2024 Feb 15. doi: 10.1111/jgh.16506. Online ahead of print. J Gastroenterol Hepatol. 2024. PMID: 38357836

8

Risk of hepatocellular carcinoma after curative treatment when switching from tenofovir disoproxil fumarate or entecavir to tenofovir alafenamide: A real-world multicenter cohort study.

Shin H, Kim SU, Song BG, Park Y, Ko Y, Park J, Hur MH, Lee YB, Cho EJ, Lee JH, Yu SJ, Yoon JH, Sinn DH, Kim YJ. Shin H, et al. Among authors: kim su. Hepatol Res. 2024 Feb 1. doi: 10.1111/hepr.14021. Online ahead of print. Hepatol Res. 2024. PMID: 38300711

9

Intact ketogenesis predicted reduced risk of moderate-severe metabolic-associated fatty liver disease assessed by liver transient elastography in newly diagnosed type 2 diabetes.

Lee S, Bae J, Kim SU, Lee M, Lee YH, Kang ES, Cha BS, Lee BW. Lee S, et al. Among authors: kim su. Front Endocrinol (Lausanne). 2024 Jan 8;14:1306134. doi: 10.3389/fendo.2023.1306134. eCollection 2023. Front Endocrinol (Lausanne). 2024. PMID: 38260169 Free PMC article.

10

Mortality in metabolic dysfunction-associated steatotic liver disease: A nationwide population-based cohort study.

Han E, Lee BW, Kang ES, Cha BS, Ahn SH, Lee YH, Kim SU. Han E, et al. Among authors: kim su. Metabolism. 2024 Mar;152:155789. doi: 10.1016/j.metabol.2024.155789. Epub 2024 Jan 13. Metabolism. 2024. PMID: 38224909

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

443 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

443 results

Results by year